 This study found that higher levels of interleukin-6, Illinois-6, are associated with longer COVID-19 infections. This suggests that Illinois-6 may be a useful biomarker for identifying individuals who are likely to develop long-term symptoms from the virus. This article was authored by Jing Zi'an Yin, Yannick Lufa Agbana, Xi Shan Sun, and others.